Search results
Unlocking Jazz Pharmaceuticals' Potential: A Roadmap for Growth
GuruFocus.com via Yahoo Finance· 2 months agoJazz Pharmaceuticals PLC (NASDAQ:JAZZ) is a fast-growing pharmaceutical company headquartered in...
Jazz Pharma ruling clears U.S. roadblock for rival narcolepsy drug
Reuters via Yahoo News· 1 year ago(Reuters) -A U.S. appeals court ordered Jazz Pharmaceuticals Inc on Friday to de-list a patent...
Axsome Triumphs Over Major Depressive Disorder With Auvelity
GuruFocus.com via Yahoo Finance· 2 months agoAxsome Therapeutics Inc. (NASDAQ:AXSM) is a fast-growing pharmaceutical company headquartered in New...
2 Dirt Cheap Growth Stocks to Buy and Hold for Years
Motley Fool· 1 year agoBuying stocks right now can seem like a bad idea given that the stock market isn't on firm footing, with the S&P 500 down 16% this year. A couple of...
10 Best Cancer Stocks to Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 10 best cancer stocks. To skip the detailed analysis of the oncology market, go directly to 5 Best Cancer Stocks to Buy...
Bipartisan senators introduce bill to close pharma competition loophole
The Hill via Yahoo News· 1 year agoSens. Maggie Hassan (D-N.H.) and Mike Braun (R-Ind.) on Wednesday reintroduced legislation intended...
2 Marijuana Stocks That Are Set for a Comeback
Motley Fool· 2 years agoMarijuana stocks have been on a roller coaster ride lately. A combination of mixed legalization rules across states, the continued illegality of...
Is Axsome Therapeutics Stock a Screaming Buy?
Motley Fool· 11 months agoAxsome Therapeutics (NASDAQ: AXSM) may have what it takes to escape this less-than-ideal fate. Since going public in 2015, Axsome's shares have...
3 Stocks That Could Double by 2025
Motley Fool· 2 years agoHere's why they chose Axsome Therapeutics (NASDAQ: AXSM), Jazz Pharmaceuticals (NASDAQ: JAZZ), and Twist Bioscience (NASDAQ: TWST). Prosper Junior Bakiny (Axsome Therapeutics): Investors intent ...
3 Stocks Savvy Investors Are Buying Hand Over Fist
Motley Fool· 2 years agoWhile the SPDR S&P Healthcare ETF is down 10% year to date, the SPDR S&P Biotech ETF has plummeted 29%. Investors should always keep the long-term...
